Tracheostomy in ICU With a Double Lumen Endotracheal Tube

July 2, 2013 updated by: Paolo Pelosi, University of Genova

Percutaneous Tracheostomy in Intensive Care Unit With a Dedicated Double Lumen Endotracheal Tube

Percutaneous tracheostomy in Intensive care unit (ICU) is performed with the use of flexible fiberoptic bronchoscope inside the conventional single lumen endotracheal tube owned by the patients. This situation may lead to many disadvantages for ventilation and airway protection of critically ill patients during the procedures. The use of double lumen endotracheal tube dedicated to the percutaneous tracheostomies may:

  1. improve the ventilation of patients during the procedure,
  2. protect the posterior tracheal wall from damage related to the different step of tracheostomies,
  3. protect the lungs from blood and secretions coming down from the chosen site of tracheostomy.

So the aim of this study is to evaluate the oxygenation, gas exchange, ventilation and complications of percutaneous tracheostomies performed in ICU with a dedicated double lumen endotracheal tube.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Genoa, Italy, 16132
        • Recruiting
        • University of Genoa
        • Contact:
        • Principal Investigator:
          • Paolo Pelosi, Professor
        • Sub-Investigator:
          • Maria Vargas, MD
      • Naples, Italy, 80100
        • Recruiting
        • University of Naples "Federico II"
        • Contact:
          • Giuseppe Servillo, Professor
          • Phone Number: +39 081 7463552
          • Email: servillo@unina.it
        • Principal Investigator:
          • Giuseppe Servillo, Professor

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years to 78 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • age ≥ 18 years and at least one of following criteria:
  • prolonged endotracheal intubation
  • prolonged mechanical ventilation
  • difficult/prolonged weaning
  • inability to protect the airway

Exclusion Criteria:

  • infection of neck tissues
  • previous surgical neck interventions
  • recent surgical interventions or fracture of the cervical spine

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Double lumen endotracheal tube tracheostomy
Tracheostomy with a dedicated double lumen endotracheal tube

Percutaneous tracheostomy in this study will be performed with the use of a dedicated double-lumen endotracheal tube.

The dedicated double-lumen endotracheal tube (Deas S.R.L, Italy) has an upper and a lower lumen. The upper one will be occupied by flexible fiberoptic bronchoscope while the lower one is exclusively dedicated to patient ventilation during the procedure. The lower lumen has a a semi-elliptical cross section. This tube will be placed in the patient airway with a direct laryngoscopy. After this intubation, a percutaneous dilatational tracheostomy will be performed with the standard techniques recognised in the literature.

Other Names:
  • International Patent n° PCT/IT2012/000154

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
change in gas-exchange
Time Frame: at the baseline and the end of the procedure (average time expected for the procedure is 30 minutes)
The investigator will perform an arterial blood gas to evaluate PaO2/FiO2 ratio
at the baseline and the end of the procedure (average time expected for the procedure is 30 minutes)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
change in arterial carbon dioxide
Time Frame: at the baseline and at the end of the procedure (average time expected for the procedure is 30 minutes)
the investigator will perform an arterial blood gas to evaluate PaCO2
at the baseline and at the end of the procedure (average time expected for the procedure is 30 minutes)
change in peak airway pressure
Time Frame: at the baseline and at the end of the procedure (average time expected for the procedure is 30 minutes)
the investigator will record peak airway pressure
at the baseline and at the end of the procedure (average time expected for the procedure is 30 minutes)
change in plateau airway pressure
Time Frame: at the baseline and at the end of the procedure (average time expected for the procedure is 30 minutes)
the investigator will record plateau airway pressure
at the baseline and at the end of the procedure (average time expected for the procedure is 30 minutes)
change in air-trapping
Time Frame: at the baseline and at the end of the procedure (average time expected for the procedure is 30 minutes)
the investigator will record auto-PEEP at the of expiration as a measure of air-trapping
at the baseline and at the end of the procedure (average time expected for the procedure is 30 minutes)
early complications
Time Frame: in the first 24 hours from the end of the procedure
early complications are:multiple intubation attempts (more than 1), accidental extubation, paratracheal insertion, injuries to blood vessels in the neck, oesophageal injury, accidental decannulation, malposition of the tracheostomy tube, tracheal cuff puncture, multiple punctures (more than 1), surgical conversion and percutaneous tracheostomy failure, minor bleeding (compressible), major bleeding (incompressible), pneumothorax,
in the first 24 hours from the end of the procedure
late complications
Time Frame: from the 2nd day ofter the procedure until the ICU discharge (expected average of 2 weeks)
late complications are: minor bleeding (compressible), major bleeding (incompressible) tracheostomy puncture site infection, subglottic stenosis, fracture of a tracheal cartilage, granuloma.
from the 2nd day ofter the procedure until the ICU discharge (expected average of 2 weeks)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Paolo Pelosi, Professor, Università degli Studi di Genova
  • Study Director: Giuseppe Servillo, Professor, Federico II University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

July 1, 2012

Primary Completion (Anticipated)

December 1, 2014

Study Completion (Anticipated)

June 1, 2015

Study Registration Dates

First Submitted

August 30, 2012

First Submitted That Met QC Criteria

September 21, 2012

First Posted (Estimate)

September 24, 2012

Study Record Updates

Last Update Posted (Estimate)

July 3, 2013

Last Update Submitted That Met QC Criteria

July 2, 2013

Last Verified

July 1, 2013

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Heart Failure

Clinical Trials on Double lumen endotracheal tube tracheostomy

Subscribe